Indapamide Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) MRI Sub-study
Conditions:   Stroke;   Cerebral Small Vessel Diseases;   Intracerebral Hemorrhage;   Vascular Dementia;   Hypertension Interventions:   Drug: telmisartan 20 mg + amlodipine 2.5mg + indapamide 1.25mg;   Drug: Placebo oral capsule Sponsors:   The George Institute;   University of Sydney Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2018 Category: Research Source Type: clinical trials